TARA is trading 3.8% down at $3.85 in pre-market on low-float biotech volatility and repositioning.

  • The move gives back part of a recent surge that followed a June 23 jump with no clear company-specific catalyst.
  • Current weakness appears to be driven by volatility in a thinly traded small-cap biotech rather than fresh news.